Barnes et al., 1989 - Google Patents
Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis.Barnes et al., 1989
View PDF- Document ID
- 3332219241930575586
- Author
- Barnes P
- Mehra V
- Hirschfield G
- Fong S
- Abou-Zeid C
- Rook G
- Hunter S
- Brennan P
- Modlin R
- Publication year
- Publication venue
- Journal of immunology (Baltimore, Md.: 1950)
External Links
Snippet
Mycobacterium tuberculosis cell walls are likely to contain critical T cell Ag capable of inducing protective immunity against the development of tuberculosis in animal models. Therefore, we characterized cell wall-associated Ag that stimulate T lymphocytes in …
- 210000004027 cells 0 title abstract description 83
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barnes et al. | Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. | |
| Melancon-Kaplan et al. | Immunological significance of Mycobacterium leprae cell walls. | |
| Beachey et al. | Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. | |
| Havlir et al. | Human immune response to Mycobacterium tuberculosis antigens | |
| Triccas et al. | A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae | |
| Chaparas et al. | The immunology of mycobacterial infections | |
| Mehra et al. | Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones. | |
| NZ513418A (en) | Vaccine comprising proteins from mycobacterium paratuberculosis | |
| ELBERG | Immunity to Brucella infection | |
| Ribi et al. | Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials | |
| Freund et al. | The effectiveness of tuberculo-glycolipid as an adjuvant in eliciting allergic encephalomyelitis and aspermatogenesis | |
| Gelber et al. | Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae | |
| KR100951057B1 (en) | Bovine tuberculosis specific enzyme immuno assay kit comprising immune specific protein antigen and other immunogens and the method for diagnosing the bovine tuberculosis by using the same | |
| Kanai et al. | Allergenicity of intracellular particles, cell walls, and cytoplasmic fluid from Mycobacterium tuberculosis | |
| Schooten et al. | T cell epitopes on the 36K and 65K Mycobacterium leprae antigens defined by human T cell clones | |
| Mohagheghpour et al. | Identification of an immunostimulating protein from Mycobacterium leprae | |
| Hasløv et al. | Biological activity in sensitized guinea pigs of MPB 70, a protein specific for some strains of Mycobacterium bovis BCG | |
| Navalkar | Immunologic analysis of Mycobacterium leprae antigens by means of diffusion-in-gel methods | |
| Munoz | Symposium on Relationship of Structure of Microorganisms to Thier Immunological Properties: I. IMMUNOLOGICAL AND OTHER BIOLOGICAL ACTIVITIES OF BORDETELLA PERTUSSIS ANTIGENS | |
| Wicher et al. | Cell response in rabbits infected with T. pallidum as measured by the leucocyte migration inhibition test. | |
| Fox et al. | Primary immunization of infants and children with group A streptococcal M protein | |
| Bhaskar et al. | Isolation, purification and immunological characterization of novel low molecular weight protein antigen CFP 6 from culture filtrate of M. tuberculosis | |
| HENDERSON et al. | EPIDEMIC TYPHUS FEVER: NEUTRALIZATION OF THE TOXIC SUBSTANCE ¹ | |
| Casavant et al. | The adjuvant activity of mycobacterial RNA preparations and synthetic polynucleotides for induction of delayed hypersensitivity to purified protein derivative in guinea pigs | |
| Ascher et al. | Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii phase I and subfractions |